Ukrainian forces strike Taganrog drone factory - Video
13:13
| Home page Health |
|
British drug manufacturer AstraZeneca has expanded its agreement with an Oxford firm to increase its production of a potential coronavirus vaccine, local media reported on Tuesday.
Axar.az reports that, the firm, Oxford Biomedica, will produce tens of millions of doses of the potential vaccine, known as AZD1222, as part of the £50 million ($66.9 million) deal.
It will do so for 18 months, with the possibility of extending it by another 18 months after that.
Production will take place in Oxford, and Astra Zeneca said its global production capacity is now close to 3 billion doses.
|
Date
2020.09.01 / 21:33
|
Author
Axar.az
|
